Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Joe Wolk
Pharma
J&J's Joaquin Duato 'optimistic' amid MFN discussions with Trump
Comments from J&J’s chief executive suggest that the company is largely aligned with many of President Donald Trump’s policy goals.
Fraiser Kansteiner
Oct 14, 2025 11:52am
J&J logs strong innovative drug sales despite Stelara's decline
Jul 16, 2025 11:19am
J&J lifts 2025 sales guidance despite looming tariff threat
Apr 15, 2025 11:55am
J&J's Kenvue spinoff provides $13.2B in potential M&A firepower
Aug 30, 2023 10:45am
J&J takes major hit from litigation cost in 2023's first quarter
Apr 18, 2023 11:15am
J&J is letting go of 64 staffers in Manhattan
Oct 20, 2022 10:59am
